Regarding GBM, a potential therapeutic opportunity was suggested through the knockdown of proteins like cFLIP, PEA-15, and RIPK1 that negatively regulate caspase-8 activation at the DISC, as silencing their expression sensitized GBM cells to TRAIL treatment47. The gene discussed is CFLAR; the disease is glioblastoma.